Abstract
The use of synthetic peptides representing cytotoxic T-cell (CTL) epitopes for human vaccination requires the identification of a suitable adjuvant formulation. A single immunization,vith Montanide ISA720/tetanus toxoid/YPHFMPTNL protected mice against murine cytomegalovirus and induced epitope-specific CTL. Such formulations will find application in peptide-based CTL anti-viral vaccines.
Original language | English |
---|---|
Pages (from-to) | 1306-1309 |
Journal | Journal of Virology |
Volume | 69 |
Publication status | Published - 1995 |